OpenURL Connection Search

Select item for more details and to access through your institution.

Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.
Published in:
Stem Cells Translational Medicine, 2020, v. 9, n. 11, p. 1331, doi. 10.1002/sctm.20-0147
By:
- Valent, Peter;
- Bauer, Karin;
- Sadovnik, Irina;
- Smiljkovic, Dubravka;
- Ivanov, Daniel;
- Herrmann, Harald;
- Filik, Yüksel;
- Eisenwort, Gregor;
- Sperr, Wolfgang R.;
- Rabitsch, Werner
Publication type:
Article
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.
Published in:
American Journal of Hematology, 2024, v. 99, n. 9, p. 1721, doi. 10.1002/ajh.27385
By:
- Bauer, Karin;
- Hauswirth, Alexander;
- Gleixner, Karoline V.;
- Greiner, Georg;
- Thaler, Johannes;
- Bettelheim, Peter;
- Filik, Yüksel;
- Koller, Elisabeth;
- Hoermann, Gregor;
- Staber, Philipp B.;
- Sperr, Wolfgang R.;
- Keil, Felix;
- Valent, Peter
Publication type:
Article
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V + Neoplastic Mast Cells.
Published in:
Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133070
By:
- Schneeweiss-Gleixner, Mathias;
- Filik, Yüksel;
- Stefanzl, Gabriele;
- Berger, Daniela;
- Sadovnik, Irina;
- Bauer, Karin;
- Smiljkovic, Dubravka;
- Eisenwort, Gregor;
- Witzeneder, Nadine;
- Greiner, Georg;
- Hoermann, Gregor;
- Schiefer, Ana-Iris;
- Schwaab, Juliana;
- Jawhar, Mohamad;
- Reiter, Andreas;
- Sperr, Wolfgang R.;
- Arock, Michel;
- Valent, Peter;
- Gleixner, Karoline V.
Publication type:
Article
STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Published in:
Cancers, 2020, v. 12, n. 4, p. 1021, doi. 10.3390/cancers12041021
By:
- Hadzijusufovic, Emir;
- Keller, Alexandra;
- Berger, Daniela;
- Greiner, Georg;
- Wingelhofer, Bettina;
- Witzeneder, Nadine;
- Ivanov, Daniel;
- Pecnard, Emmanuel;
- Nivarthi, Harini;
- Schur, Florian K. M.;
- Filik, Yüksel;
- Kornauth, Christoph;
- Neubauer, Heidi A.;
- Müllauer, Leonhard;
- Tin, Gary;
- Park, Jisung;
- de Araujo, Elvin D.;
- Gunning, Patrick T.;
- Hoermann, Gregor;
- Gouilleux, Fabrice
Publication type:
Article

Found: 4

Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues.

BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V + Neoplastic Mast Cells.

STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.